Is Eli Lilly xStock (LLYX) Halal or Haram?
SUMMARY
Eli Lilly xStock (LLYx) is a permissible tokenized stock. The underlying company, Eli Lilly, operates a halal pharmaceutical business and passes all AAOIFI financial screens. The token wrapper by Backed Finance is a fully collateralized 1:1 tracker certificate with no embedded leverage. As impure income is estimated at under 5%, purification of dividends and gains is required.
Verdict by Activity
How you can hold and use LLYX
Buy & Hold
The underlying company is a permissible pharmaceutical business passing all financial screens, and the token is a fully collateralized 1:1 tracker certificate without embedded leverage.
Dividends
Dividends accrue to the tokenholder and are passed as additional tokens or USDC; a portion (under 5%) must be purified due to the company's interest income.
Shariah Component Breakdown
Shariah Analysis
Infrastructure
PassedIssued on neutral general-purpose networks including Ethereum, Solana, and Base, which do not taint a properly backed tokenized share.
Business Activity (Underlying Company)
PassedThe underlying company is a pure-play pharmaceutical business with no involvement in haram industries, and does not extend consumer credit.
Token Structure
PassedThe token wraps ordinary common equity and is backed 1:1 with no embedded leverage. The holder owns a debt obligation of the issuer (tracker certificate) rather than the share itself, meaning its value depends on the issuer's solvency as well as the share price.
Asset Qualification
PassedThe holder owns a documented debt obligation of the issuer (tracker certificate) that is backed 1:1 by custodied shares and attested on-chain, rather than direct title to the shares.
Financial Screens (AAOIFI Ratios)
PassedThe underlying company passes AAOIFI screens with a debt ratio of 4.90% and cash/securities ratio of 1.15%. Impure income is under 5%, requiring purification.
Legitimacy & Security
social presence
CautionNot covered by research.
project audits
PassedReserves are attested by an independent audit firm (The Network Firm) and published on-chain via Chainlink Proof of Reserve.
whitepaper
PassedIssuer documentation, legal form, and redemption rights are clearly documented and available.
Team & Ecosystem
team background
CautionNot covered by research.
Detailed Shariah Report
Overview
Eli Lilly xStock (LLYx) is a tokenized stock issued by Backed Finance that tracks the price of Eli Lilly and Company shares on a 1:1 basis. Rather than providing direct legal ownership of the underlying shares, the token represents a fully collateralized debt obligation (tracker certificate) against the issuer. It allows investors to gain economic exposure to the pharmaceutical company's performance on blockchain networks like Ethereum, Solana, and Base.
Why This Verdict
The Shariah compliance of this asset is evaluated across three layers: the underlying infrastructure, the asset's utility, and its qualification as recognized property. The underlying networks (Ethereum, Solana, Base, etc.) are neutral, general-purpose blockchains; hosting other applications does not taint this specific token. As a digital asset, the token qualifies as recognized property (Mal) because it represents an exclusive, protocol-recognized right of control that presently exists, is ascertainable, transferable, can be held and preserved, and carries a lawful economic use. Regarding the verdict on simply buying and holding the token, it is Halal. The underlying company, Eli Lilly, operates a permissible pharmaceutical business with no involvement in prohibited industries and passes all AAOIFI financial screens (debt ratio of 4.90% and cash/securities ratio of 1.15%). Furthermore, the token wrapper is a 1:1 tracker certificate with no embedded leverage or margin. Regarding the asset's mechanisms, the Dividends feature is also Halal and operates automatically. The economic value of dividends accrues to the tokenholder and is distributed as additional tokens or USDC. Because the underlying company earns a small amount of interest income on its cash equivalents, a portion of these dividends must be purified.
Permissible Aspects
- The underlying business is a pure-play pharmaceutical company focused on human health (including Diabetes/Obesity treatments like Mounjaro and Zepbound), with no exposure to prohibited industries.
- The company passes AAOIFI financial screens, maintaining a low debt-to-market-cap ratio of 4.90% and a cash-to-market-cap ratio of 1.15%.
- The token is fully collateralized 1:1 by custodied shares, with reserves attested by an independent audit firm (The Network Firm) and published on-chain via Chainlink Proof of Reserve.
- The token wrapper contains no embedded leverage, margin, or predetermined returns.
Points of Caution
- !Legal Nature: Tokenholders own a documented debt obligation (tracker certificate) against the issuer, Backed Finance, rather than direct legal title to the underlying Eli Lilly shares. The token's value therefore depends on the issuer's solvency as well as the share price.
- !The underlying company earns a small amount of interest income from its cash equivalents, which necessitates the purification of dividends.
- !Research did not cover the social presence or the specific backgrounds of the team behind the tokenization platform, warranting standard investor due diligence.
Purification Note
Purification is required. Because Eli Lilly earns interest income from its cash equivalents, impure income is estimated at under 5% of total revenue. Investors must purify this percentage of any dividend distributions received (whether in tokens or USDC) by donating it to charity.
BOTTOM LINE
Eli Lilly xStock (LLYx) is a permissible tokenized stock that offers 1:1 economic exposure to a Shariah-compliant pharmaceutical company. While holding the token and receiving dividends are Halal, investors should note they hold a tracker certificate against the issuer rather than direct shares, and must purify a small portion of their dividend returns. Please note that this is an analytical report, and final religious authority rests with a qualified Shariah scholar.
How this verdict was reached
This is not an opinion issued by ShariaQuant. It is the output of a documented screening methodology applied to researched facts about Eli Lilly xStock (LLYX), and every row above states the specific evidence that drove it — so the reasoning can be examined rather than taken on trust.
The framework screens the underlying company's business activity, the tokenisation wrapper (whether the token is genuinely backed by real shares with a clear legal claim, and free of embedded leverage), and what the holder actually owns — direct title, a documented claim on custodied shares, or bare price exposure.
The financial screens follow the AAOIFI screening standard: interest-bearing debt below 30% of market capitalisation, cash and interest-bearing securities below 30%, and non-compliant income below 5% of revenue, with a purification estimate wherever any impure income exists.
The framework follows published scholarship rather than in-house opinion. Treating a digital asset as a right (ḥaqq) that becomes recognised property (māl) only on stated conditions follows “Is Crypto Halal? The Definitive Shariah Guide to Crypto and Digital Assets” by Mufti Faraz Adam (Amanah Advisors, 2026), which reproduces the conditions identified by Mufti Taqi Usmani. Financial thresholds follow the AAOIFI screening standard. The rulings we track are collected in the fatwa library.
AAOIFI has not reviewed, approved or endorsed this report or ShariaQuant, and no scholar named in our methodology has reviewed this individual verdict. This is analysis, not a fatwa — final religious authority rests with a qualified scholar.
Is Eli Lilly xStock a serious project?
Permissible is not the same as good. This is the research behind that second question — what Eli Lilly xStock is actually for, who is paying for it, what is already built, and what would have to go wrong.
Research on the project, not advice on the trade. A high fundamental score is not a recommendation to buy, and it says nothing about whether the asset is permissible — that is the Shariah verdict, and it is free.
How Eli Lilly xStock ranks against its peers
The Shariah verdict tells you whether you may own Eli Lilly xStock. This tells you what you would be holding — measured from market data, with no AI judgment in it, and compared only against assets of the same kind.
A ranking of how solid an asset is against its peers, not a forecast of what it will do next and not investment advice. A permissible asset can rank badly, and a badly ranked asset can still rise.
About Eli Lilly xStock
Eli Lilly xStock (LLYx) is a permissible tokenized stock. The underlying company, Eli Lilly, operates a halal pharmaceutical business and passes all AAOIFI financial screens. The token wrapper by Backed Finance is a fully collateralized 1:1 tracker certificate with no embedded leverage. As impure income is estimated at under 5%, purification of dividends and gains is required.
Asked alongside this
Short answers from the ShariaQuant team.
Knowing it passes is the easy half
Eli Lilly xStock passing the screen does not tell you how to buy it without leverage, how much of your portfolio it should be, or when to sell. The free module covers the fiqh those decisions rest on.
Both are free. The module includes the community — no card required.